Baseline� Guide: Risk-Based Manufacture of Pharmaceutical Products (Risk-MaPP)

Print this page         
 

Released: 8 September 2010

Formats Member Price Nonmember Price  
Bound Version $200 / €195 $510 / €455 buy now
Individual Download $200 / €195 $510 / €455 buy now

Baseline® Guide: Risk-Based Manufacture of Pharmaceutical Products (Risk-MaPP) provides a scientific risk-based approach, based on ICH Q9 Quality Risk Management, to manage the risk of cross contamination in order to achieve and maintain an appropriate balance between product quality and operator safety. If you are involved with multi-product facilities, this document is an essential tool for you.

My ISPE

  • Click to go to My Communities of Practice
  • Click to go to My Affiliate or Chapter
  • Click to go to My Profile

ISPEAK Logo

An ISPE
Information
Resource

Design Considerations for WFI Distillation Systems Part 2
Thursday, 28 Apr 2016 18.04

2016 Annual Meeting Honorary Chair, Joseph Jimenez, Novartis
Tuesday, 26 Apr 2016 12.04

Pharmaceutical Training to Meet Your Needs
Friday, 22 Apr 2016 16.04